The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Disturbances of gait and postural stability in chronic cerebral ischemia

Read: 29263 times


To cite this article:

Disturbances of gait and postural stability in chronic cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(1):78‑84. (In Russ.)
https://doi.org/10.17116/jnevro20171171178-84

References:

  1. Jahno N.N., Preobrazhenskaja I.S., Zaharov V.V., Stepkina D.A., Lokshina A.V., Mhitarjan Je.A., Koberskaja N.N., Savushkina I.Ju. Rasprostranennost' kogpitivnyh narushenij pri nevrologicheskih zabolevanijah (analiz raboty specializirovannogo ambulatornogo priema). Nevrologija, nejropsihiatrija, psihosomatika. 2012;(2):30-34.
  2. Zaharov V.V. Vserossijskaja programma issledovanij jepidemiologii i terapii kognitivnyh rasstrojstv v pozhilom vozraste («Prometej»). Nevrologicheskij zhurnal. 2006;(11):27-32.
  3. Jahno N.N., Levin O.S., Damulin I.V. Sopostavlenie klinicheskih i MRT-dannyh pri discirkuljatornoj jencefalopatii. Soobshhenie 2: kognitivnye narushenija. Nevrologicheskij zhurnal. 2001;6(3):10-19.
  4. Preobrazhenskaja I.S., Jahno N.N. Sosudistye kognitivnye narushenija: klinicheskie projavlenija, diagnostika, lechenie. Nevrologicheskij zhurnal. 2007;12(5):45-50.
  5. Hachinski VC, Lassen NA, Marshall Y Multi-infarct dementia: a cause of mental deterioration in the elderly. Lancet. 1974;2:207.
  6. Bolezn' Al'cgejmera i sosudistaja demencija. Pod red. Jahno N.N. M. 2002;85.
  7. Bryzhahina V.G., Damulin I.V. Statolokomotornye narushenija u pozhilyh bol'nyh s discirkuljatornoj jencefalopatiej i demenciej. Vestnik prakticheskoj nevrologii. 2003;7:17-21.
  8. Bryzhahina V.G., Damulin I.V., Jahno N.N. Narushenija hod'by i ravnovesija pri discirkuljatornoj jencefalopatii. Soobshhenie 1. Nevrologicheskij zhurnal. 2004;9(2):11-16.
  9. Damulin I.V., Bryzhahina V.G., Shashkova E.V., Jahno N.N. Narushenija hod'by i ravnovesija pri discirkuljatornoj jencefalopatii. Soobshhenie 2. Kliniko-morfologicheskie i MRT sopostavlenija. Nevrologicheskij zhurnal. 2004;9(4):13-18.
  10. Bennet DA, Wilson RS, Gilley DW, Fox JH. Clinical diagnosis of Binswanger’s disease. J Neurology Neurosurgery and Psychiatry. 1990;53:961-965.
  11. Huisa BN, Rosenberg GA. Binswanger’s disease: diagnosis and management. Exp Rev Neuther. 2014;14(10):1203-1213. doi:10.1586/14737175.2014.956726
  12. Thompson PD, Marsden CD. Gait disturbances of subcortical arteriosclerotic enchepalopathy: Binswanger’s disease. Mov Disord. 1987;2(1):1-8.
  13. Thompson PD. Frontal lobe ataxia. Handb Clin Neurol. 2012;103:619-622. doi:10.1016/B978-0-444-51892-7.00044-9
  14. Zadikoff C, Lang AE. Apraxia in movement disorders. Brain. 2005;128(7):1480-1497.
  15. Thanvi B, Lo N, Robinson T. Vascular parkinsonism — a important cause of parkinsonism in older people. Age and aging. 2005;34(2):114-119.
  16. Vizcarra JA, Lang AE, Sethi KD, Espay AJ. Vascular parkinsonism: deconstructing the syndrome. Mov Disord. 2015;30(7):886-894. doi:10.1002/mds.26263
  17. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol. 1999;56:98-102.
  18. Jahno N.N., Levin O.S., Damulin I.V. Sopostavlenie klinicheskih i MRT-dannyh pri discirkuljatornoj jencefalopatii. Soobshhenie 1: dvigatel'nye narushenija. Nevrologicheskij zhurnal. 2001;6(2):10-16.
  19. Blahak C, Baezner H, Pantoni L et al. Deep frontal and periventicular white matter changes but not basal ganglia and infratentorial hyperintensities are associates with falls: cross-sectional results from LADIS study. J Neurol Neurosurg Psych. 2009;80(6):608-613.
  20. Hoffman M. The human frontal lobes and frontal network systems: an evolutionary, clinical and treatment perspective. ISRN Neurology. 2013;2013:892459. doi:10.1155/2013/892459
  21. Hershey LA, Olszewski WA. Ischemic vascular dementia. In: Handbook of Demented Illnesses. Ed. by J.C. Morris. New York etc.: Marcel Dekker, Inc; 1994.
  22. Nutt JG, Marsden CD, Thompson PD. Human walking and higher-level gait disorders, particularly in the elderly. Neurology. 1993;43:268-279.
  23. Liston R, Mickelborough J, Bene J, Tallis R. A new classification of higher level gait disorders in patients with cerebral multi-infarct states. Age Ageing. 2003;32:252-258.
  24. Chang CM, Yu YL, Ng HK, Leung SY, Fong KY. Vascular pseudoparkinsonism. Acta Neurol Scand. 1992;86:588-592.
  25. Hennerici MG, Oster M, Cohen S, Schwartz A, Motsch L, Daffertshofer M. Are gait disturbances and white matter degeneration early indicators of vascular dementia? Dementia. 1994;5:197-202.
  26. Schiller F. Staggering gait in medical history. Ann Neurol. 199;37:127-133.
  27. Zamergrad M.V. Golovokruzhenie s diagnozom discirkuljatornaja jencefalopatija. Med Sovet. 2014;5:22-26. doi:10.21518/2079-701X-2014-5-22-26
  28. Neverovskiĭ D.V., Sluchevskaja S.F, Parfenov V.A. Differencial'nyĭ diagnoz discirkuljatornoĭ jencefalopatii v ambulatornoĭ praktike. Nevrologija, neĭropsihiatrija, psihosomatika. 2013;2:38-42.
  29. Parfenov V.A., Zamergrad M.V. Golovokruzhenie v nevrologicheskoĭ praktike. Nevrologicheskiĭ zhurnal. 2005;1:4-11.
  30. Forette F, Seux ML, Staessen JA et al. Prevention of dementia in randomised double-blind placebo controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352:1347-1351.
  31. Tzourio C, Anderson C, Chapman N et al. PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003;1069-1075.
  32. Isolated systolic hypertension: lowering the risk of stroke in older patients. SHEP Cooperative Research Group. Petrovitch H, Vogt TM, Berge KG. Geriatrics. 1992;47(3):30-32, 35-38.
  33. Diener HC, Sacco RL, Yusuf S et al. Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) Study Group. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo controlled study. Lancet Neurol. 2008;7:875-884.
  34. Lithell H, Hansson L, Skoog I et al. SCOPE Study Group. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003;21:875-886.
  35. Peters R, Beckett N, Forette F et al. HYVET Investigators. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol. 2008;7:683-689.
  36. Yusuf S, Diener HC, Sacco RL et al. PRoFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008;359:1225-1237.
  37. Trompet S, van Vliet P, de Craen AJ et al. Pravastatin and cognitive function in the elderly: results of the PROSPER study. J Neurol. 2010;257:85-90. doi:10.1007/s00415-009-5271-7
  38. Price JF, Stewart MC, Deary IJ et al. Low dose aspirin and cognitive function in middle aged to elderly adults: randomized controlled trial. BMJ. 2008;337:1198. doi:10.1136/bmj.a1198
  39. Gutiérrez-Fernández M, Rodríguez-Frutos B, Fuentes B, Vallejo- Cremades MT, Alvarez-Grech J, Expósito-Alcaide M, Díez-Tejedor E. CDP-choline treatment induces brain plasticity markers expression in experimental animal stroke. Neurochem Int. 2012;60(3):310-317. doi:10.1016/j.neuint.2011.12.015
  40. Secades JJ. Citicoline: pharmacological and clinical review, 2010 update. Rev Neurol. 2011;52(suppl 2):1-62.
  41. Arenth PM, Russell KC, Ricker JH, Zafonte RD. CDP-choline as a biological supplement during neurorecovery: a focused review. PM R. 2011;(6 suppl 1):123-131. doi:10.1016/j.pmrj.2011.03.012
  42. Takasaki K, Uchida K, Fujikawa R, Nogami A, Nakamura K, Kawasaki C, Yamaguchi K, Morita M, Morishita K, Kubota K, Katsurabayashi S, Mishima K, Fujiwara M, Iwasaki K.Neuroprotective effects of citidine-5- diphosphocholine on impaired spatial memory in a rat model of cerebrovascular dementia. J Pharmacol Sci. 2011;116(2):232-237.
  43. Hurtado O, Lizasoain I, Moro MÁ. Neuroprotection and recovery: recent data at the bench on citicoline. Stroke. 2011;42(1):33-35. doi:10.1161/STROKEAHA.110.597435
  44. Weiss GB. Metabolism and actions of CDPcholine as an endogenous compound and administered exogenously as citicoline. Life Sci. 1995;56:637-660.
  45. Agnoli A, Bruno G, Fioravanti M. Therapeutic approach to senile memory impairment: a double-blind clinical trial with CDP choline. In: Wurtman RJ, Corkin S, Growden JH, eds. Alzheimer’s Disease: Proceedings of the Fifth Meeting of the International Study Group on the Pharmacology of Memory Disorders Associated with Aging. Boston, MA: Birkhauser; 1989;649-654.
  46. Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database of Systematic Reviews. 2005;(2):CD000269.
  47. Abad-Santos F, Novalbos-Reina J, Gallego-Sandín S, García AG. Tratamiento del deterioro cognitivo lieve: utilidad de la citicolina. Rev Neurol. 2002;35:675-682.
  48. Caamargo J, Gûmez MJ, Franco A, Cacabelos R. Effects of CDP- choline on cognition and cerebral hemodynamics in patients with Alzheimer’s disease. Methods Find Exp Clin Pharmacol. 1994;16:211-218.
  49. Petrova D, Maslarov D, Angelov I, Zekin D. Analysis of Therapeutic Efficacy of Citicoline in Patients with Vertigo of Central Origin and Vascular Aetiology. American Journal of Neuroprotection and Neuroregeneration. 2012;4:1-8.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.